Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-CHLORO-4-(CHLOROMETHYL)-6-METHYLPYRIDINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

162046-59-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 162046-59-5 Structure
  • Basic information

    1. Product Name: 2-CHLORO-4-(CHLOROMETHYL)-6-METHYLPYRIDINE
    2. Synonyms: 2-CHLORO-4-(CHLOROMETHYL)-6-METHYLPYRIDINE
    3. CAS NO:162046-59-5
    4. Molecular Formula: C7H7Cl2N
    5. Molecular Weight: 176.04318
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 162046-59-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 258.8±35.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.270±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 1.09±0.10(Predicted)
    10. CAS DataBase Reference: 2-CHLORO-4-(CHLOROMETHYL)-6-METHYLPYRIDINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-CHLORO-4-(CHLOROMETHYL)-6-METHYLPYRIDINE(162046-59-5)
    12. EPA Substance Registry System: 2-CHLORO-4-(CHLOROMETHYL)-6-METHYLPYRIDINE(162046-59-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 162046-59-5(Hazardous Substances Data)

162046-59-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 162046-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,0,4 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 162046-59:
(8*1)+(7*6)+(6*2)+(5*0)+(4*4)+(3*6)+(2*5)+(1*9)=115
115 % 10 = 5
So 162046-59-5 is a valid CAS Registry Number.

162046-59-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-4-(chloromethyl)-6-methylpyridine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:162046-59-5 SDS

162046-59-5Relevant articles and documents

CGRP RECEPTOR ANTAGONISTS

-

Page/Page column 56; 57; 59, (2017/03/25)

The present invention provides a compound of Formula II: (II) or a pharmaceutically acceptable salt thereof.

CGRP RECEPTOR ANTAGONISTS

-

Page/Page column 20; 45; 47, (2017/03/08)

The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt thereof.

N-(PYRIDIN-2-YL)PYRIMIDIN-4-AMINE DERIVATIVES CONTAINING A SULFONE GROUP

-

, (2014/05/07)

The present invention relates to N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorder

N-(PYRIDIN-2-YL)PYRIMIDIN-4-AMINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP

-

, (2014/06/11)

The present invention relates to disubstituted N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/ or prophylaxis of disorders, in particular of hyper- proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP

-

, (2014/06/11)

The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

HETEROCYCLIC ANTI-MIGRAINE AGENTS

-

Page/Page column 182-183, (2008/06/13)

The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

-

, (2008/06/13)

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 162046-59-5